Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Investigating cognition in midlife

JS. Novotný, JP. Gonzalez-Rivas, JR. Medina-Inojosa, F. Lopez-Jimenez, YE. Geda, GB. Stokin

. 2021 ; 7 (1) : e12234. [pub] 20211231

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22010353

We here posit that measurements of midlife cognition can be instructive in understanding cognitive disorders. Even though molecular events signal possible onset of cognitive disorders decades prior to their clinical diagnoses, cognition and its possible early changes in midlife remain poorly understood. We characterize midlife cognition in a cognitively healthy population-based sample using the Cogstate Brief Battery and test for associations with cardiovascular, adiposity-related, lifestyle-associated, and psychosocial variables. Learning and working memory showed significant variability and vulnerability to psychosocial influences in midlife. Furthermore, midlife aging significantly and progressively increased prevalence of suboptimal cognitive performance. Our findings suggest that physiological changes in cognition, measured with simple tests suitable for use in everyday clinical setting, may signal already in midlife the first clinical manifestations of the presymptomatic biologically defined cognitive disorders. This pilot study calls for longitudinal studies investigating midlife cognition to identify clinical correlates of biologically defined cognitive disorders.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22010353
003      
CZ-PrNML
005      
20220425131812.0
007      
ta
008      
220420s2021 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1002/trc2.12234 $2 doi
035    __
$a (PubMed)35005209
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Novotný, Jan S $u Translational Aging and Neuroscience Program, Centre for Translational Medicine, International Clinical Research Centre St. Anne's University Hospital Brno Czech Republic
245    10
$a Investigating cognition in midlife / $c JS. Novotný, JP. Gonzalez-Rivas, JR. Medina-Inojosa, F. Lopez-Jimenez, YE. Geda, GB. Stokin
520    9_
$a We here posit that measurements of midlife cognition can be instructive in understanding cognitive disorders. Even though molecular events signal possible onset of cognitive disorders decades prior to their clinical diagnoses, cognition and its possible early changes in midlife remain poorly understood. We characterize midlife cognition in a cognitively healthy population-based sample using the Cogstate Brief Battery and test for associations with cardiovascular, adiposity-related, lifestyle-associated, and psychosocial variables. Learning and working memory showed significant variability and vulnerability to psychosocial influences in midlife. Furthermore, midlife aging significantly and progressively increased prevalence of suboptimal cognitive performance. Our findings suggest that physiological changes in cognition, measured with simple tests suitable for use in everyday clinical setting, may signal already in midlife the first clinical manifestations of the presymptomatic biologically defined cognitive disorders. This pilot study calls for longitudinal studies investigating midlife cognition to identify clinical correlates of biologically defined cognitive disorders.
655    _2
$a časopisecké články $7 D016428
700    1_
$a Gonzalez-Rivas, Juan P $u Kardiovize Study, International Clinical Research Centre St. Anne's University Hospital Brno Czech Republic $u Department of Global Health and Population Harvard TH Chan School of Public Health Harvard University Boston Massachusetts USA
700    1_
$a Medina-Inojosa, Jose R $u Division of Preventive Cardiology, Department of Cardiovascular Medicine, Mayo Clinic Rochester Minnesota USA
700    1_
$a Lopez-Jimenez, Francisco $u Division of Preventive Cardiology, Department of Cardiovascular Medicine, Mayo Clinic Rochester Minnesota USA
700    1_
$a Geda, Yonas E $u Division of Alzheimer's Disease and Memory Disorders Program Department of Neurology Barrow Neurological Institute Phoenix Arizona USA
700    1_
$a Stokin, Gorazd B $u Translational Aging and Neuroscience Program, Centre for Translational Medicine, International Clinical Research Centre St. Anne's University Hospital Brno Czech Republic $u Translational Aging and Neuroscience Program Mayo Clinic Rochester Minnesota USA $u Division of Neurology University Medical Centre Ljubljana Slovenia
773    0_
$w MED00205981 $t Alzheimer's & dementia (New York, N. Y.) $x 2352-8737 $g Roč. 7, č. 1 (2021), s. e12234
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35005209 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20220420 $b ABA008
991    __
$a 20220425131810 $b ABA008
999    __
$a ind $b bmc $g 1784562 $s 1161551
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 7 $c 1 $d e12234 $e 20211231 $i 2352-8737 $m Alzheimer's & dementia $n Alzheimers Dement (N Y) $x MED00205981
LZP    __
$a Pubmed-20220420
Zpět

Najít záznam

Citační ukazatele

Možnosti archivace